These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 11572146)

  • 1. Advances in medical biological defense technology.
    Culpepper RC; Pratt WD
    Clin Lab Med; 2001 Sep; 21(3):679-89. PubMed ID: 11572146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Personal protection against biological warfare agents].
    Eisenkraft A; Cohen A; Krasner E; Hourvitz A
    Harefuah; 2002 May; 141 Spec No():105-10, 118. PubMed ID: 12170544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Advances in detecting and responding to threats from bioterrorism and emerging infectious disease.
    Rotz LD; Hughes JM
    Nat Med; 2004 Dec; 10(12 Suppl):S130-6. PubMed ID: 15577931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological warfare: disease prevention and post exposure medical treatment].
    Robenshtok E; Katz L; Brenner B; Sagi R
    Harefuah; 2002 May; 141 Spec No():57-62, 121. PubMed ID: 12170556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccines against biologic agents: uses and developments.
    Ales NC; Katial RK
    Respir Care Clin N Am; 2004 Mar; 10(1):123-46. PubMed ID: 15062232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Viruses, bacteria and toxins as biological warfare].
    Hansen JE
    Ugeskr Laeger; 1999 Feb; 161(6):772-5. PubMed ID: 10028879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for military use.
    Artenstein AW
    Vaccine; 2009 Nov; 27 Suppl 4():D16-22. PubMed ID: 19837279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Old legacies and new paradigms: confusing "research" and "treatment" and its consequences in responding to emergent health threats.
    Javitt GH
    J Health Care Law Policy; 2005; 8(1):38-70. PubMed ID: 16538801
    [No Abstract]   [Full Text] [Related]  

  • 9. Biological threat characterization research: a critical component of national biodefense.
    Petro JB; Carus WS
    Biosecur Bioterror; 2005; 3(4):295-308. PubMed ID: 16366839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Policies in place throughout the world: action by the European Union.
    Gouvras G
    Int J Infect Dis; 2004 Oct; 8 Suppl 2():S21-30. PubMed ID: 15491872
    [No Abstract]   [Full Text] [Related]  

  • 11. Preventing the use of biological weapons: improving response should prevention fail.
    Inglesby TV; O'Toole T; Henderson DA
    Clin Infect Dis; 2000 Jun; 30(6):926-9. PubMed ID: 10880302
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current biodefense vaccine programs and challenges.
    Wolfe DN; Florence W; Bryant P
    Hum Vaccin Immunother; 2013 Jul; 9(7):1591-7. PubMed ID: 23428906
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [National preparedness for biological mass casualty event: between the devil and the deep blue sea].
    Eldad A
    Harefuah; 2002 May; 141 Spec No():21, 123. PubMed ID: 12170548
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Protection against bioterrorism acts in Poland].
    Chomiczewski K
    Przegl Epidemiol; 2003; 57(2):363-8. PubMed ID: 12910607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunization against potential biological warfare agents.
    Cieslak TJ; Christopher GW; Kortepeter MG; Rowe JR; Pavlin JA; Culpepper RC; Eitzen EM
    Clin Infect Dis; 2000 Jun; 30(6):843-50. PubMed ID: 10880299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleic acid approaches for detection and identification of biological warfare and infectious disease agents.
    Ivnitski D; O'Neil DJ; Gattuso A; Schlicht R; Calidonna M; Fisher R
    Biotechniques; 2003 Oct; 35(4):862-9. PubMed ID: 14579752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Medical planning considerations in consequence management.
    Marghella PD
    Front Health Serv Manage; 2002; 19(1):15-23. PubMed ID: 12355629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strengthening the US Medical Countermeasure Enterprise for Biological Threats.
    Ravi S; Adalja AA
    Health Secur; 2017; 15(1):12-14. PubMed ID: 28092470
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulism and vaccines for its prevention.
    Smith LA
    Vaccine; 2009 Nov; 27 Suppl 4():D33-9. PubMed ID: 19837283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.